| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S V Hemanth, Saravanan Alagarsamy, T Dhiliphan Rajkuma. A novel deep learning model for diabetic retinopathy detection in retinal fundus images using pre-trained CNN and HWBLSTM. Journal of biomolecular structure & dynamics. 2024-02-19. PMID:38373067. |
diabetic retinopathy (dr) is a global visual indicator of diabetes that leads to blindness and loss of vision. |
2024-02-19 |
2024-02-22 |
Not clear |
| Ian Gerard Brennan, Stephen R Kelly, Edel McBride, Darragh Garrahy, Robert Acheson, Joanne Harmon, Shane McMahon, David J Keegan, Helen Kavanagh, Louise O'Tool. Addressing Technical Failures in a Diabetic Retinopathy Screening Program. Clinical ophthalmology (Auckland, N.Z.). vol 18. 2024-02-15. PMID:38356695. |
diabetic retinopathy (dr) is a preventable cause of blindness detectable through screening using retinal digital photography. |
2024-02-15 |
2024-02-17 |
Not clear |
| Samuel Cubillos, Andrius Kazlauska. Manifestation of Pathology in Animal Models of Diabetic Retinopathy Is Delayed from the Onset of Diabetes. International journal of molecular sciences. vol 25. issue 3. 2024-02-10. PMID:38338889. |
diabetic retinopathy (dr) is the most common complication that develops in patients with diabetes mellitus (dm) and is the leading cause of blindness worldwide. |
2024-02-10 |
2024-02-12 |
Not clear |
| Akshit Aggarwal, Shruti Jain, Himanshu Jinda. Computational Model for the Detection of Diabetic Retinopathy in 2-D Color Fundus Retina Scan. Current medical imaging. 2024-02-09. PMID:38333976. |
dr accounts for 5% to 7% of all blindness in the entire area. |
2024-02-09 |
2024-02-11 |
Not clear |
| Huma Naz, Rahul Nijhawan, Neelu Jyothi Ahuj. Clinical utility of handheld fundus and smartphone-based camera for monitoring diabetic retinal diseases: a review study. International ophthalmology. vol 44. issue 1. 2024-02-09. PMID:38334896. |
diabetic retinopathy (dr) is the leading global cause of vision loss, accounting for 4.8% of global blindness cases as estimated by the world health organization (who). |
2024-02-09 |
2024-02-11 |
Not clear |
| Binita Bhattarai, Hari Bahadur Thapa, Sandip Bashyal, Sarasawati Khadka Thapa, Sirshendu Chaudhuri, Varun Agiwal, Hira Pant, Samiksha Singh, Hemant Mahaja. Structured Counselling and Regular Telephonic follow up to improve Referral flow and compliance in Nepal for Diabetic Retinopathy(SCREEN-D Study): a randomised controlled trial. BMC health services research. vol 24. issue 1. 2024-02-09. PMID:38336691. |
diabetic retinopathy (dr) is an emerging public health issue, leading to severe visual impairment or blindness. |
2024-02-09 |
2024-02-12 |
Not clear |
| Xing-Li Wang, Yang Xian, Xiao-Long Che. YAP/TAZ Signaling Enhances Angiogenesis of Retinal Microvascular Endothelial Cells in a High-Glucose Environment. Current eye research. 2024-02-02. PMID:38305219. |
diabetic retinopathy (dr) is a major cause of irreversible blindness in the working-age population. |
2024-02-02 |
2024-02-04 |
human |
| Jazlan Jamaluddin, Mohd Azzahi Mohamed Kame. Underprescription of Fibrate Among Patients With Diabetic Retinopathy in Perak, Malaysia. Cureus. vol 16. issue 1. 2024-02-01. PMID:38298309. |
objectives diabetic retinopathy (dr) is a major cause of blindness and its prevalence is increasing. |
2024-02-01 |
2024-02-03 |
Not clear |
| Jie Bian, Weizhong Ge, Zhengmei Jian. miR-26a-5p Attenuates Oxidative Stress and Inflammation in Diabetic Retinopathy through the USP14/NF- Journal of ophthalmology. vol 2024. 2024-01-29. PMID:38282961. |
mir-26a-5p attenuates oxidative stress and inflammation in diabetic retinopathy through the usp14/nf- diabetic retinopathy (dr) is an ocular disease caused by diabetes and may lead to vision impairment and even blindness. |
2024-01-29 |
2024-01-31 |
Not clear |
| Amandeep Kaur, Ranjeet Kumar, Amit Sharm. Diabetic Retinopathy Leading to Blindness- A Review. Current diabetes reviews. 2024-01-26. PMID:38275038. |
diabetic retinopathy (dr) is the most common microvascular complication of diabetes that damages the retina, leading to blindness. |
2024-01-26 |
2024-01-28 |
Not clear |
| Charles R Cleland, Covadonga Bascaran, William Makupa, Bernadetha Shilio, Frank A Sandi, Heiko Philippin, Ana Patricia Marques, Catherine Egan, Adnan Tufail, Pearse A Keane, Alastair K Denniston, David Macleod, Matthew J Burto. Artificial intelligence-supported diabetic retinopathy screening in Tanzania: rationale and design of a randomised controlled trial. BMJ open. vol 14. issue 1. 2024-01-25. PMID:38272554. |
globally, diabetic retinopathy (dr) is a major cause of blindness. |
2024-01-25 |
2024-01-28 |
Not clear |
| Po Hsiang Shawn Yuan, Arman Athwal, Mena Shalaby, Andrew Mehnert, Dao-Yi Yu, Rony C Preti, Marinko Sarunic, Eduardo V Navaja. Retinal capillary perfusion heterogeneity in diabetic retinopathy detected by optical coherence tomography angiography. International journal of retina and vitreous. vol 10. issue 1. 2024-01-25. PMID:38273321. |
diabetic retinopathy (dr) is a leading cause of blindness and involves retinal capillary damage, microaneurysms, and altered blood flow regulation. |
2024-01-25 |
2024-01-28 |
Not clear |
| Wenlong Li, Linbo Bian, Baikai Ma, Tong Sun, Yiyun Liu, Zhengze Sun, Lin Zhao, Kang Feng, Fan Yang, Xiaona Wang, Szyyann Chan, Hongliang Dou, Hong Q. Interpretable Detection of Diabetic Retinopathy, Retinal Vein Occlusion, Age-Related Macular Degeneration, and Other Fundus Conditions. Diagnostics (Basel, Switzerland). vol 14. issue 2. 2024-01-22. PMID:38247998. |
diabetic retinopathy (dr), retinal vein occlusion (rvo), and age-related macular degeneration (amd) pose significant global health challenges, often resulting in vision impairment and blindness. |
2024-01-22 |
2024-01-24 |
Not clear |
| Luyuan Tan, Zhaonan Wang, Kelvin Okoth, Konstantinos A Toulis, Alastair K Denniston, Baldev M Singh, Francesca L Crowe, Christopher Sainsbury, Jingya Wang, Krishnarajah Nirantharakuma. Associations of antidiabetic drugs with diabetic retinopathy in people with type 2 diabetes: an umbrella review and meta-analysis. Frontiers in endocrinology. vol 14. 2024-01-19. PMID:38239984. |
diabetic retinopathy (dr) is the most frequent complication of type 2 diabetes and remains the leading cause of preventable blindness. |
2024-01-19 |
2024-01-21 |
Not clear |
| Irma Suwandi Sadikin, Yeni Dwi Lestari, Andi Arus Victo. The role of cadre in the community on diabetic retinopathy management and its challenges in low-middle income countries: a scoping review. BMC public health. vol 24. issue 1. 2024-01-15. PMID:38225623. |
diabetic retinopathy (dr) is one of the most prevalent diabetic microvascular problems, and early diagnosis through eye screening programs for people with diabetes is critical to prevent vision impairment and blindness. |
2024-01-15 |
2024-01-18 |
Not clear |
| Panpan Wu, Yue Qu, Ziping Zhao, Yue Cui, Yurou Xu, Peng An, Hengyong Y. An adaptive weighted ensemble learning network for diabetic retinopathy classification. Journal of X-ray science and technology. 2024-01-13. PMID:38217630. |
diabetic retinopathy (dr) is one of the leading causes of blindness. |
2024-01-13 |
2024-01-16 |
Not clear |
| Si-Yu Gui, Xin-Chen Wang, Zhi-Hao Huang, Mei-Mei Li, Jia-Hao Wang, Si-Yin Gui, Gan-Hua Zhang, Yao Lu, Li-Ming Tao, Hai-Sheng Qian, Zheng-Xuan Jian. Nanoscale coordination polymer Fe-DMY downregulating Poldip2-Nox4-H Journal of pharmaceutical analysis. vol 13. issue 11. 2024-01-04. PMID:38174114. |
nanoscale coordination polymer fe-dmy downregulating poldip2-nox4-h diabetic retinopathy (dr) is a prevalent microvascular complication of diabetes and the leading cause of blindness and severe visual impairment in adults. |
2024-01-04 |
2024-01-06 |
Not clear |
| Shenping Li, Dandan Sun, Shimei Chen, Shuchang Zhang, Qing Gu, Yinchen Shen, Li Xu, Xun Xu, Fang Wei, Ning Wan. UCP2-SIRT3 Signaling Relieved Hyperglycemia-Induced Oxidative Stress and Senescence in Diabetic Retinopathy. Investigative ophthalmology & visual science. vol 65. issue 1. 2024-01-04. PMID:38175638. |
diabetic retinopathy (dr) is one of the most common reasons for blindness. |
2024-01-04 |
2024-01-06 |
Not clear |
| Ling Dai, Bin Sheng, Tingli Chen, Qiang Wu, Ruhan Liu, Chun Cai, Liang Wu, Dawei Yang, Haslina Hamzah, Yuexing Liu, Xiangning Wang, Zhouyu Guan, Shujie Yu, Tingyao Li, Ziqi Tang, Anran Ran, Haoxuan Che, Hao Chen, Yingfeng Zheng, Jia Shu, Shan Huang, Chan Wu, Shiqun Lin, Dan Liu, Jiajia Li, Zheyuan Wang, Ziyao Meng, Jie Shen, Xuhong Hou, Chenxin Deng, Lei Ruan, Feng Lu, Miaoli Chee, Ten Cheer Quek, Ramyaa Srinivasan, Rajiv Raman, Xiaodong Sun, Ya Xing Wang, Jiarui Wu, Hai Jin, Rongping Dai, Dinggang Shen, Xiaokang Yang, Minyi Guo, Cuntai Zhang, Carol Y Cheung, Gavin Siew Wei Tan, Yih-Chung Tham, Ching-Yu Cheng, Huating Li, Tien Yin Wong, Weiping Ji. A deep learning system for predicting time to progression of diabetic retinopathy. Nature medicine. 2024-01-04. PMID:38177850. |
diabetic retinopathy (dr) is the leading cause of preventable blindness worldwide. |
2024-01-04 |
2024-01-07 |
human |
| Thiara S Ahmed, Janika Shah, Yvonne N B Zhen, Jacqueline Chua, Damon W K Wong, Simon Nusinovici, Rose Tan, Gavin Tan, Leopold Schmetterer, Bingyao Ta. Ocular microvascular complications in diabetic retinopathy: insights from machine learning. BMJ open diabetes research & care. vol 12. issue 1. 2024-01-03. PMID:38167606. |
diabetic retinopathy (dr) is a leading cause of preventable blindness among working-age adults, primarily driven by ocular microvascular complications from chronic hyperglycemia. |
2024-01-03 |
2024-01-06 |
Not clear |